Special items: Ovarian Cancer and Us blog best viewed in Firefox

Thursday, March 17, 2011

media - FDA OKs sixth gadolinium-based MRI contrast agent (also known as Gadavist/Gadovist)

Gadavist, known as Gadovist

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.